DOCSLIB.ORG

OKAP Content Outline

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
OKAP Content Outline Ophthalmic Knowledge Assessment Program OKAP® Examination CONTENT OUTLINE American Academy of Ophthalmology P.O. Box 7424 San Francisco, CA 94120-7424 © 2017 American Academy of Ophthalmology All rights reserved TABLE OF CONTENTS OKAP Content Outline Section Page 1. GENERAL MEDICINE 1 2. FUNDAMENTALS AND PRINCIPLES OF OPHTHALMOLOGY 4 3. CLINICAL OPTICS 7 4. OPHTHALMIC PATHOLOGY AND INTRAOCULAR TUMORS 13 5. NEURO-OPHTHALMOLOGY 19 6. PEDIATRIC OPHTHALMOLOGY AND STRABISMUS 24 7. ORBIT, EYELIDS, AND LACRIMAL SYSTEM 34 8. EXTERNAL DISEASE AND CORNEA 40 9. INTRAOCULAR INFLAMMATION AND UVEITIS 47 10. GLAUCOMA 51 11. LENS AND CATARACT 53 12. RETINA AND VITREOUS 58 13. REFRACTIVE SURGERY 64 CONTENT OUTLINE Content Outline Number SECTION 1: GENERAL MEDICINE .............................................................................................1.0 Scored as part of Subtest 1: General Medicine Infectious Disease .......................................................................................................................1.1 Staphylococcus .................................................................................................................1.1.1 Streptococcus ...................................................................................................................1.1.2 Neisseria...........................................................................................................................1.1.3 Pseudomonas aeruginosa .................................................................................................1.1.4 Treponema pallidum .........................................................................................................1.1.5 Borrelia burgdorferi ...........................................................................................................1.1.6 Chlamydia trachomatis ......................................................................................................1.1.7 Mycoplasma pneumonia ...................................................................................................1.1.8 Mycobacteria ....................................................................................................................1.1.9 Tuberculosis .........................................................................................................1.1.9.1 Fungal Infections...............................................................................................................1.1.10 Toxoplasma ......................................................................................................................1.1.11 Herpesvirus.......................................................................................................................1.1.12 Herpes Simplex ....................................................................................................1.1.12.1 Varicella-Zoster ....................................................................................................1.1.12.2 Cytomegalovirus ...................................................................................................1.1.12.3 Epstein-Barr Virus ................................................................................................1.1.12.4 Influenza ...........................................................................................................................1.1.13 Hepatitis............................................................................................................................1.1.14 Hepatitis A ............................................................................................................1.1.14.1 Hepatitis B ............................................................................................................1.1.14.2 Hepatitis C and Other Forms of Hepatitis ..............................................................1.1.14.3 Human Papillomavirus ......................................................................................................1.1.15 Acquired Immunodeficiency Syndrome ..............................................................................1.1.16 Etiology and Pathogenesis ...................................................................................1.1.16.1 Clinical Syndromes ...............................................................................................1.1.16.2 Seroepidemiology .................................................................................................1.1.16.3 Modes of Transmission .........................................................................................1.1.16.4 Prognosis and Treatment......................................................................................1.1.16.5 Opportunistic Infections ........................................................................................1.1.16.6 Ophthalmic considerations ....................................................................................1.1.16.7 Update on Antibiotics ........................................................................................................1.1.17 Antibacterial Agents ..............................................................................................1.1.17.1 New Antibiotic Classes .........................................................................................1.1.17.2 Antifungal Agents .................................................................................................1.1.17.3 Antiviral Agents ....................................................................................................1.1.17.4 Hypertension ...............................................................................................................................1.2 Classification of Blood Pressure and Diagnosis of Hypertension ........................................1.2.1 Etiology and Pathogenesis of Hypertension .......................................................................1.2.2 Evaluation of Hypertension................................................................................................1.2.3 Treatment of Hypertension ................................................................................................1.2.4 Lifestyle Modifications...........................................................................................1.2.4.1 1 Pharmacologic Treatment .....................................................................................1.2.4.2 Antihypertensive Drugs .....................................................................................................1.2.5 Special Considerations......................................................................................................1.2.6 Cerebrovascular Disease ............................................................................................................1.3 Cerebral Ischemia .............................................................................................................1.3.1 Carotid Occlusive Disease ................................................................................................1.3.2 Intracranial Hemorrhage ....................................................................................................1.3.3 Acquired Heart Disease...............................................................................................................1.4 Ischemic Heart Disease ....................................................................................................1.4.1 Congestive Heart Failure ...................................................................................................1.4.2 Disorders of Cardiac Rhythm ............................................................................................1.4.3 Hypercholesterolemia .................................................................................................................1.5 Risk Assessment ..............................................................................................................1.5.1 Management .....................................................................................................................1.5.2 Pulmonary Diseases....................................................................................................................1.6 Hematologic Disorders................................................................................................................1.7 Anemia .............................................................................................................................1.7.1 Disorders of Hemostasis ...................................................................................................1.7.2 Rheumatic Disorders ...................................................................................................................1.8 Rheumatoid Arthritis..........................................................................................................1.8.1 Spondyloarthropathies ......................................................................................................1.8.2 Systemic Lupus Erythematosus ........................................................................................1.8.3 Antiphospholipid Antibody Syndrome ................................................................................1.8.4 Scleroderma .....................................................................................................................1.8.5 Sjogren Syndrome ............................................................................................................1.8.6
Load more

Recommended publications
  • Giant Anterior Staphyloma After Bomb Explosion Bomba Patlaması Sonrası Gelişen Dev Anterior Stafilom
    Case Report/Olgu Sunumu İstanbul Med J 2021; 22(1): 78-80 DO I: 10.4274/imj.galenos.2020.88864 Giant Anterior Staphyloma After Bomb Explosion Bomba Patlaması Sonrası Gelişen Dev Anterior Stafilom İbrahim Ali Hassan, İbrahim Abdi Keinan, Mohamed Salad Kadiye, Mustafa Kalaycı Somali Mogadişu-Turkey Recep Tayyip Erdoğan Training and Research Hospital, Clinic of Eye, Mogadishu, Somalia ABSTRACT ÖZ A 64-year-old male patient was admitted to our clinic Altmış dört yaşında erkek hasta sol gözünde ağrı şikayeti ile complaining of pain in his left eye. Three years ago, the patient kliniğimize başvurdu. Hastanın 3 yıl önce sol gözüne araç içi was hit in the left eye by a metal object during an in-car bomb bomba patlaması sırasında metal bir cisim çarpmıştı. Hastanın explosion. The patient had a giant anterior staphyloma in his sol gözünde kapakların kapanmasını engelleyen dev anterior left eye that prevented the eyelids from closing. In the shiotz stafilom vardı. Shiotz tonometre ölçümünde sol göz içi basıncı tonometer measurement, the left intraocular pressure was 26 26 mmHg idi. Bilgisayarlı tomografide stafiloma uç noktası ile mmHg. In computed tomography, the distance between the lens arasındaki mesafe 7,17 mm idi. Açık glob travmasından staphyloma endpoint and the lens was 7.17 mm. After open sonra hastalar, oküler yüzey enfeksiyonları açısından düzenli glob trauma, patients should be checked at short intervals takip için kısa aralıklarla kontrol edilmelidir. Hastadan for regular follow-up for ocular surface infections. The sorumlu göz doktoru, hastanın ilaca uyumunu ve gözün ilaca ophthalmologist responsible for the patient should regularly verdiği yanıtı düzenli olarak değerlendirmelidir.
    [Show full text]
  • Disseminated Tuberculosis Presenting with Scrofuloderma and Anterior Staphyloma in a Child in Sokoto, Nigeria
    Journal of Tuberculosis Research, 2020, 8, 127-135 https://www.scirp.org/journal/jtr ISSN Online: 2329-8448 ISSN Print: 2329-843X Disseminated Tuberculosis Presenting with Scrofuloderma and Anterior Staphyloma in a Child in Sokoto, Nigeria Khadijat O. Isezuo1* , Ridwan M. Jega1 , Bilkisu I. Garba1 , Usman M. Sani1 , Usman M. Waziri1 , Olubusola B. Okwuolise1 , Hassan M. Danzaki2 1Department of Paediatrics, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria 2Department of Ophthalmology, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria How to cite this paper: Isezuo, K.O., Jega, Abstract R.M., Garba, B.I., Sani, U.M., Waziri, U.M., Okwuolise, O.B. and Danzaki, H.M. (2020) Introduction: Disseminated tuberculosis (TB) may occur with skin and ocu- Disseminated Tuberculosis Presenting with lar involvement which are not common manifestations in children and may Scrofuloderma and Anterior Staphyloma in lead to debilitating complications. Objective: A child with multi-organ TB a Child in Sokoto, Nigeria. Journal of Tu- berculosis Research, 8, 127-135. involving the lungs, chest abdomen, skin and eyes who had been symptomat- https://doi.org/10.4236/jtr.2020.83011 ic for 3 years is reported. Case Report: A 6-year-old girl presented with re- current fever, abdominal pain and weight loss of 3 years and skin lesions of a Received: June 1, 2020 year duration. There was history of pain and redness of the eyes associated Accepted: August 3, 2020 Published: August 6, 2020 with discharge. She was not vaccinated at all. She was chronically ill-looking with bilateral conjunctival hyperaemia, purulent eye discharge with corneal Copyright © 2020 by author(s) and opacity of the right eye.
    [Show full text]
  • The Height of the Posterior Staphyloma and Corneal Hysteresis Is
    Downloaded from http://bjo.bmj.com/ on August 30, 2016 - Published by group.bmj.com Clinical science The height of the posterior staphyloma and corneal hysteresis is associated with the scleral thickness at the staphyloma region in highly myopic normal-tension glaucoma eyes Jong Hyuk Park,1 Kyu-Ryong Choi,2 Chan Yun Kim,1 Sung Soo Kim1 1Department of Ophthalmology, ABSTRACT optic nerve head (ONH) in eyes with high – Institute of Vision Research, Aims To evaluate the characteristics of the posterior myopia.8 10 Yonsei University College of Medicine, Seoul, Republic of segments of eyes with high myopia and normal-tension Recent studies have demonstrated the importance Korea glaucoma (NTG) and identify which ocular factors are of the posterior ocular structures such as the lamina 2Department of Ophthalmology most associated with scleral thickness and posterior cribrosa and sclera in the pathogenesis of glau- – and Institute of Ophthalmology staphyloma height. coma.8 10 The mechanical influence of the peripa- & Optometry, Ewha Womans Methods The study included 45 patients with highly pillary sclera on the lamina cribrosa is considered University School of Medicine, Seoul, Republic of Korea myopic NTG and 38 controls with highly myopic eyes to be important in that scleral deformations affect (≤−6D or axial length ≥26.0 mm). The subfoveal the stiffness and thickness of the sclera and affect Correspondence to retinal, choroidal, scleral thickness and the posterior the ONH biomechanics by exacerbating strain and Professor Sung Soo Kim, staphyloma heights were examined from enhanced depth stress.11 The increased risk of glaucoma in myopic Department of Ophthalmology, College of Medicine, Yonsei imaging spectral-domain optical coherence tomography eyes may be related in part to the mechanical prop- University, 134 Sinchon-dong, and compared between two groups.
    [Show full text]
  • CURRICULUM VITAE Morton Falk Goldberg, MD, FACS, FAOSFRACO
    CURRICULUM VITAE Morton Falk Goldberg, M.D., F.A.C.S., F.A.O.S. F.R.A.C.O. (Hon), M.D. (Hon., University Coimbra) PERSONAL DATA: Born, June 8, 1937 Lawrence, MA, USA Married, Myrna Davidov 5/6/1968 Children: Matthew Falk Michael Falk EDUCATION: A.B., Biology – Magna cum laude, 1958 Harvard College, Cambridge MA Detur Prize, 1954-1955 Phi Beta Kappa, Senior Sixteen 1958 M.D., Medicine – Cum Laude 1962 Lehman Fellowship 1958-1962 Alpha Omega Alpha, Senior Ten 1962 INTERNSHIP: Department of Medicine, 1962-1963 Peter Bent Brigham Hospital, Boston, MA RESIDENCY: Assistant Resident in Ophthalmology 1963-1966 Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, MD CHIEF RESIDENT: Chief Resident in Ophthalmology Mar. 1966-Jun. 1966 Yale-New Haven Hospital Chief Resident in Ophthalmology, Jul. 1966-Jun. 1967 Wilmer Ophthalmological Institute Johns Hopkins Hospital BOARD CERTIFICATION: American Board of Ophthalmology 1968 Page 1 CURRICULUM VITAE Morton Falk Goldberg, M.D., F.A.C.S., F.A.O.S. F.R.A.C.O. (Hon), M.D. (Hon., University Coimbra) HONORARY DEGREES: F.R.A.C.O., Honorary Fellow of the Royal Australian 1962 College of Ophthalmology Doctoris Honoris Causa, University of Coimbra, 1995 Portugal MEDALS: Inaugural Ida Mann Medal, Oxford University 1980 Arnall Patz Medal, Macula Society 1999 Prof. Isaac Michaelson Medal, Israel Academy Of 2000 Sciences and Humanities and the Hebrew University- Hadassah Medical Organization David Paton Medal, Cullen Eye Institute and Baylor 2002 College of Medicine Lucien Howe Medal, American Ophthalmological
    [Show full text]
  • COVID-19'S IMPACT
    EARN 2 CE CREDITS: Maximizing OCT in the Diagnosis of Glaucoma, p. 76 May 15, 2020 www.reviewofoptometry.com COVID-19’s IMPACT …and How Optometry Can Bounce Back THERE’S RELIEF AND THEN THERE’S Its disruptions were swift and seismic, but ODs are ready to move on. • Planning for Post-COVID Life, p. 3 • Patient Care Morphs During COVID-19, p. 30 • 20 Tips FORFor Reopening DRY, Amid COVID-19, IRRITATED p. 36 EYES. The only family of products in the U.S. with CMC, HA (inactive ingredient), and HydroCell™ technology. ALSO: 21st Annual Dry Eye Report, begins p. 42 refreshbrand.com/doc Statins and the Eye: What You May Not Know, p. 62 © 2020 Allergan. All rights reserved. All trademarks are the property of their respective owners. REF127591 08/19 Five Cases You Shouldn’t Refer, p. 68 EARN 2 CE CREDITS: Maximizing OCT in the Diagnosis of Glaucoma, p. 76 May 15, 2020 www.reviewofoptometry.com COVID-19’s IMPACT …and How Optometry Can Bounce Back Its disruptions were swift and seismic, but ODs are ready to move on. • Planning for Post-COVID Life, p. 3 • Patient Care Morphs During COVID-19, p. 30 • 20 Tips For Reopening Amid COVID-19, p. 36 ALSO: 21st Annual Dry Eye Report, begins p. 42 Statins and the Eye: What You May Not Know, p. 62 Five Cases You Shouldn’t Refer, p. 68 INTRODUCING VISUAL FIELD SUITE M&S | Melbourne Rapid Fields (MRF) Revolutionary Visual Field Testing MRF is a simple solution, meticulously designed and calibrated to perform Visual Field tests in-clinic and at home, developed by a name you can trust.
    [Show full text]
  • An Atypical Case of Recurrent Cellulitis/Lymphangitis in a Dutch Warmblood Horse Treated by Surgical Intervention A
    EQUINE VETERINARY EDUCATION / AE / JANUARY 2013 23 Case Report An atypical case of recurrent cellulitis/lymphangitis in a Dutch Warmblood horse treated by surgical intervention A. M. Oomen*, M. Moleman, A. J. M. van den Belt† and H. Brommer Department of Equine Sciences and †Companion Animals, Division of Diagnostic Imaging, Faculty of Veterinary Medicine, Utrecht University, Yalelaan, Utrecht, The Netherlands. *Corresponding author email: [email protected] Keywords: horse; lymphangitis; lymphoedema; surgery; lymphangiectasia Summary proposed as a possible contributing factor for chronic The case reported here describes an atypical presentation progressive lymphoedema of the limb in these breeds of of cellulitis/lymphangitis in an 8-year-old Dutch Warmblood horses (de Cock et al. 2003, 2006; Ferraro 2003; van mare. The horse was presented with a history of recurrent Brantegem et al. 2007). episodes of cellulitis/lymphangitis and the presence of Other diseases related to the lymphatic system are fluctuating cyst-like lesions on the left hindlimb. These lesions lymphangioma/lymphangiosarcoma and development appeared to be interconnected lymphangiectasias. Surgical of lymphangiectasia. Cutaneous lymphangioma has been debridement followed by primary wound closure and local described as a solitary mass on the limb, thigh or inguinal drainage was performed under general anaesthesia. Twelve region of horses without the typical signs of progressive months post surgery, no recurrence of cellulitis/lymphangitis lymphoedema (Turk et al. 1979; Gehlen and Wohlsein had occurred and the mare had returned to her former use as 2000; Junginger et al. 2010). Lymphangiectasias in horses a dressage horse. have been described in the intestinal wall of foals and horses with clinical signs of colic and diarrhoea (Milne et al.
    [Show full text]
  • Rod-Cone Dystrophy Associated with the Gly167asp Variant in PRPH2
    Rod-cone dystrophy associated with the Gly167Asp variant in PRPH2 Rola Ba-Abbad, FRCS, PhD1,2, Anthony G. Robson, PhD1,2, Becky MacPhee, BSc2, Andrew R. Webster, MD(Res), FRCOpth1,2, Michel Michaelides, MD(Res), FRCOphth 1,2 1. UCL Institute of Ophthalmology, University College London, London, UK 2. Moorfields Eye Hospital, London, UK Declaration of interest statement: the authors report no conflict of interest. Corresponding Author: Professor Michel Michaelides, MD(Res), FRCOphth UCL Institute of Ophthalmology, London, EC1V 9EL, United Kingdom Email: [email protected] Phone number: +44 (0) 20 7608 6800 Peripherin 2-associated retinopathies are phenotypically heterogenous and can present as autosomal dominant retinitis pigmentosa, cone-rod dystrophy, various forms of macular and pattern dystrophy, or recessive retinopathy1,2. We report a case of rod-cone dystrophy associated with the variant c.500G>A, p.(Gly167Asp) in PRPH2 (OMIM 179605), which was previously reported to cause autosomal dominant butterfly-shaped pigment dystrophy of the fovea in a three-generation pedigree (MIM 169150)3. A 66-year old British woman of European ancestry was referred to the inherited retinal disorders clinic with bilateral pigmentary retinopathy, and a 5-year history of nyctalopia. There were no knowingly affected family members; her late father and mother had normal vision in their sixties and eighties respectively, and the patient’s two children had no symptoms in their third decade of life. Previously, she underwent laser refractive surgery for myopia, bilateral cataract extraction and laser posterior capsulotomy. On examination, the Snellen visual acuity was 20/30 in the right eye, and 20/80 in the left eye; and color vision (Ishihara plates) was normal bilaterally.
    [Show full text]
  • Lympho Scintigraphy and Lymphangiography of Lymphangiectasia
    supplement to qualitative interpretation of scintiscans, pulmo 13. Hirose Y, lmaeda T, Doi H, Kokubo M, Sakai 5, Hirose H. Lung perfusion SPECT in nary perfusion scintigraphy will become a more useful tech predicting postoperative pulmonary function in lung cancer. Ann Nuc/ Med 1993:7: 123—126. nique for clinical evaluation of treatment and assessment of 14. Hosokawa N, Tanabe M, Satoh K. et al. Prediction of postoperative pulmonary breathlessness and respiratory failure than the usual one. function using 99mTcMAA perfusion lung SPECT. Nippon Ada Radio/ 1995;55:414— 422. 15. Richards-Catty C, Mishkin FS. Hepatic activity on perfusion lung images. Semi,, Nuci REFERENCES Med l987;l7:85—86. I. Wagner UN Jr. Sabiston DC ir, McAee JG, Tow D, Stem HS. Diagnosis of massive 16. Kitani K, Taplin GV. Biliary excretion of9@―Tc-albuminmicroaggregate degradation pulmonaryembolism in man by radioisotopescanning.N Engli Med 1964;27l:377-384. products (a method for measuring Kupifer cell digestive function?). J Naic! Med 2. Maynard CD. Cowan Ri. Role of the scan in bronchogenic carcinoma. Semin Nuci 1972:13:260—265. Med 1971;l:195—205. 17. Marcus CS, Parker LS, Rose 1G. Cullison RC. Grady P1. Uptake of ‘@“Tc-MAAby 3. Newman GE, Sullivan DC, Gottschalk A, Putman CE. Scintigraphic perfusion pattems the liver during a thromboscintigram/lung scan. J Nuci Med 1983;24:36—38. in patients with diffuse lung disease. Radiology 1982;l43:227—23l. 18. Gates GF, Goris ML. Suitability of radiopharmaceuticals for determining right-to-left 4. Clarke SEM, Seeker-Walker RH. Lung scanning.
    [Show full text]
  • DJO Macular Dystrophy in a Post LASIK Patient
    DJO Vol. 30, No. 3, January-March 2020 Case Report Macular Dystrophy in a Post LASIK Patient Sanjana Vatsa, Shana Sood Dr. Agarwal Eye Hospital, Chennai, Tamil Nadu, India LASIK (Laser Assisted Insitu keratomileusis) is the most commonly performed refractive surgery worldwide. A detailed pre operative and post operative evaluation of the anterior and posterior segment is a must. A 35 year old male patient with a history of LASIK surgery done 13 years back presented to us with complaint of painless, progressive diminution of vision in both eyes from past Abstract 2 years. Dilated retinal examination showed bulls eye maculopathy in both eyes. Macular OCT showed gross reduction in central foveal thickness. ERG showed marked reduction in photopic responses suggestive of a cone dystrophy. Treatment aims at alleviating the symptoms and use of low vision aids. Genetic counselling may be of benefit for affected individuals and their families. Delhi J Ophthalmol 2020;30;60-62; Doi http://dx.doi.org/10.7869/djo.529 Keywords: LASIK, Bulls eye maculopathy, cone dystrophy, genetic counselling. Introduction LASIK is the most popular and commonly performed refractive surgery worldwide.1 Along with anterior segment, a detailed evaluation of the posterior segment is a must on follow up visits to rule out any retinal lesions such as degenerations, dystrophies, maculopathy etc; as these can occur irrespective of any procedure performed. Case Report A 35 year old male patient came to us with a history of LASIK surgery done 13 years back in both eyes for a power of -7.0D sphere. Patient was comfortable with his vision after surgery and had no complaints for 11 years, after which he noticed blurring of vision in both eyes (more in the left eye).
    [Show full text]
  • Congenital Dacryocystocele: Our Experience
    Research Article American Journal of Otolaryngology and Head and Neck Surgery Published: 15 Jan, 2021 Congenital Dacryocystocele: Our Experience Hetal Marfatia, Swapna Patil and Pankaj Goyal* Department of Otorhinolaryngology & Head-Neck Surgery, Seth G.S. Medical College and KEM Hospital, India Abstract Objective: To study the presentation, complications, and treatment protocols for infants with congenital dacryocystocele. Patients and Methods: We performed a retrospective study of all infants presenting with dacryocystoceles to our tertiary centre between the years of 2014 to 2019. Results: Fourteen infants and newborns with dacryocystocele were identified (10 males, 4 females); median age of presentation was 28 days. Nine of fourteen patients presented with dacryocystocele, four responded to conservative treatment, five of them underwent forced syringing three patients responded while two were subjected to probing and failing which they underwent endoscopic Dacryocystorhinostomy (DCR). Two of fourteen presented with lacrimal fistula which needed endoscopic DCR with closure of fistula. Emergency endoscopic DCR was performed for two of fourteen patients with Acute Dacryocystitis. One patient had intranasal cyst at the opening of Hasner’s valve which was dealt with endoscopic marsupialization. Conclusion: Congenital dacryocystoceles may get infected if not intervened timely. Early referral and intervention can avoid complications. Forced syringing and probing may help in opening the block in nasolacrimal system there by avoid the need for DCR. Those presenting with acute Dacryocystitis and lacrimal fistula forced syringing and probing was avoided due to fear of false passage and were subjected to endoscopic DCR with good result. Keywords: Dacryocystocele; Complication; Endoscopic dacryocystorhinostomy; Forced syringing; Probing OPEN ACCESS Introduction *Correspondence: Congenital dacryocystocele is an uncommon consequence of congenital nasolacrimal duct Pankaj Goyal, Department of obstruction.
    [Show full text]
  • The Clinical Efficacy of Dietary Fat Restriction in Treatment of Dogs
    J Vet Intern Med 2014;28:809–817 The Clinical Efficacy of Dietary Fat Restriction in Treatment of Dogs with Intestinal Lymphangiectasia H. Okanishi, R. Yoshioka, Y. Kagawa, and T. Watari Background: Intestinal lymphangiectasia (IL), a type of protein-losing enteropathy (PLE), is a dilatation of lymphatic vessels within the gastrointestinal tract. Dietary fat restriction previously has been proposed as an effective treatment for dogs with PLE, but limited objective clinical data are available on the efficacy of this treatment. Hypothesis/Objectives: To investigate the clinical efficacy of dietary fat restriction in dogs with IL that were unrespon- sive to prednisolone treatment or showed relapse of clinical signs and hypoalbuminemia when the prednisolone dosage was decreased. Animals: Twenty-four dogs with IL. Methods: Retrospective study. Body weight, clinical activity score, and hematologic and biochemical variables were compared before and 1 and 2 months after treatment. Furthermore, the data were compared between the group fed only an ultra low-fat (ULF) diet and the group fed ULF and a low-fat (LF) diet. Results: Nineteen of 24 (79%) dogs responded satisfactorily to dietary fat restriction, and the prednisolone dosage could be decreased. Clinical activity score was significantly decreased after dietary treatment compared with before treat- ment. In addition, albumin (ALB), total protein (TP), and blood urea nitrogen (BUN) concentration were significantly increased after dietary fat restriction. At 2 months posttreatment, the ALB concentrations in the ULF group were signifi- cantly higher than that of the ULF + LF group. Conclusions and Clinical Importance: Dietary fat restriction appears to be an effective treatment in dogs with IL that are unresponsive to prednisolone treatment or that have recurrent clinical signs and hypoalbuminemia when the dosage of prednisolone is decreased.
    [Show full text]
  • The Role of Erg/Vep and Eye Movement Recordings in Children with Ocular Motor Apraxia
    THE ROLE OF ERG/VEP AND EYE MOVEMENT RECORDINGS IN CHILDREN WITH OCULAR MOTOR APRAXIA FATIMA S. SHAWKAT, CHRISTOPHER M. HARRIS, DAVID S. I. TAYLOR and ANTHONY KRISS London SUMMARY several reports of OMA or saccade failure occurring Ocular motor apraxia (OMA) is characterised by an congenitally, with no other clinical entity?-5 How­ intermittent inability to initiate voluntary sacca des, and ever, it can also occur as part of a wider neurological a failure to produce optokinetic and vestibular quick disorder: for example with structural brain abnorm­ phases. Some patients have no other abnormalities alities, such as agenesis of the corpus callosum6 and (idiopathic OMA), whereas in others it appears vermis hypoplasia;7 with neurodegenerative condi­ associated with a variety of neurological conditions tions;8 and with acquired neurological disease such as which may affect the sensory visual pathway. Electro­ posterior fossa tumours,9 ataxia telangiectasia,lO retinograms (ERGs), flash and pattern visual evoked fronto-parietal lesions,l1.l2 occipital cortex lesions,13 potentials (VEPs) and eye movements were assessed in cerebellar and brains tern neoplasm14 and olivoponto­ 53 children with OMA (age range 17 days to 14 years) cerebellar degeneration. 15.16 The inability to gener­ to determine their efficacy in helping to distinguish ate saccades often leads to the development of between idiopathic and non-idiopathic cases. Seven patients (13.2%) had idiopathic OMA and the remain­ compensatory behaviour to shift direction of gaze; ing 46 (86.8%) had other associated clinical conditions. this includes headthrusting, blinking and tilted head All patients had episodes of absent quick phases ('lock posture, which enables the use of vertical eye up') during optokinetic nystagmus (OKN) and/or movements that are usually unaffected.
    [Show full text]